| Literature DB >> 35223235 |
Sevcan İpek1, Ahmet Şahin2, Sukru Gungor3, Sadık Yurttutan4, Ufuk U Güllü5, Sermin Inal6, Şeyma Demiray7.
Abstract
BACKGROUND: Nosocomial infections are a global threat to human health worldwide. AIM: This study aimed to investigate the change of nosocomial infection factors in equivalent historical periods in pediatric patients without COVID-19 before and during the pandemic in the pediatric intensive care unit.Entities:
Keywords: children; covid-19; nosocomial infections; pandemic; pediatric intensive care unit
Year: 2022 PMID: 35223235 PMCID: PMC8860675 DOI: 10.7759/cureus.21451
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Non-COVID-19 PICU infection rates and proper hand hygiene prior to and during the COVID-19 pandemic
PICU, pediatric intensive care unit
| Variable | 2019 | 2020 |
| Infection rate | ||
| Patient count | 332 | 221 |
| Inpatient days | 2,377 | 2,260 |
| Infection count | 17 | 10 |
| Rate | 5.12 | 4.52 |
| Density | 7.15 | 4.43 |
| Hand hygiene compliance | ||
| Appropriate observation count | 110 | 179 |
| Total observation count | 116 | 180 |
| Compliance rate (%) | 94.83 | 99.44 |
Non-COVID-19 PICU infections and antibiotic resistance prior to and during the COVID-19 pandemic
CLABSI, central-line-associated bloodstream infections; VAP, ventilator-associated pneumonia; ESBL, extended-spectrum β-lactamase; PICU, pediatric intensive care unit
| Variable | 2019 | 2020 |
| CLABSI | ||
| Count | 8 (47%) | 5 (50%) |
| Rate | 2.41 | 2.26 |
| Density | 3.37 | 2.21 |
| VAP | ||
| Count | 9 (53%) | 2 (20%) |
| Rate | 2.71 | 0.9 |
| Density | 3.79 | 0.44 |
| Meningitis/ventriculitis | ||
| Count | - | 1 (10%) |
| Rate | - | 0.45 |
| Density | - | 0.44 |
| Decubitus ulcer | ||
| Count | - | 1 (10%) |
| Rate | - | 0.45 |
| Density | - | 0.44 |
| Clinically defined pneumonia | ||
| Count | - | 1 (10%) |
| Rate | - | 0.45 |
| Density | - | 0.44 |
| Resistance: ESBL | ||
|
| 83.33 | 50 |
| Resistance: KARBAPENEM | ||
|
| 100 | 100 |
|
| 66.67 | 50 |
|
| 60 | - |
| Resistance: KOLISTIN | ||
|
| 0 | 16.67 |
| Resistance: VRE | ||
|
| 100 | - |
|
| 100 | - |
Characteristics of patients who developed infection in non-COVID-19 PICU before and during COVID-19 pandemic
aFisher's exact, bMann-Whitney U test, cChi-square test
TPN: total parenteral nutrition
| Variable | 2019 | 2020 | p |
| Sex (female/male) | 7/5 | 3/5 | 0.65a |
| Age (months) median (min-max) | 16.5 (3-178) | 35.5 (10-152) | 0.23b |
| Weight (kg) median (min-max) | 7.4 (2.4-42) | 15.5 (6.5-50) | 0.9b |
| 30-day mortality | 5 (29.4%) | 2(20%) | 0.67a |
| Length of hospital stay (days) median (min-max) | 120 (19-343) | 75 (23-168) | 0.48b |
| Proton-pump inhibitor | 14 (82.4%) | 7 (87.5%) | 1a |
| Steroid | 4 (23.5) | 0 | 0.26a |
| TPN | 3 (17.6%) | 0 | 0.27a |
| Central venous catheter and port | 15 (88.2%) | 6 (60%) and port 3(30%) | 0.56c |
Figure 1Nosocomial infection agents (count) prior to and during the COVID-19 pandemic.
Figure 2Nosocomial infection agents (%) prior to and during the COVID-19 pandemic.